Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aino Health ABFRA:50V 33 EV-to-EBIT is -4.78 as of Aug. 19, 2026. GuruFocus rates FRA:50V with a GF Score™ of 33/100. The stock has 4 warning signs investors should review. Among 473 Healthcare Providers & Services companies, Aino Health AB ranks worse than 211416.28% on this metric.
The historical rank and industry rank for Aino Health AB's EV-to-EBIT or its related term are showing as below:
FRA:50V'
s EV-to-EBIT Range Over the Past 10 Years
Min: -30 Med: -2.63 Max: -0.32
Current: -4.84
During the past 12 years, the highest EV-to-EBIT of Aino Health AB was -0.32. The lowest was -30.00. And the median was -2.63.
FRA:50V's EV-to-EBIT is ranked worse than 100% of 473
companies
in the Healthcare Providers & Services industry
Industry Median: 15.81
vs FRA:50V: -4.84
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Aino Health AB's Enterprise Value for the quarter that ended in Jun. 2026 was €-0.07 Mil.
Aino Health AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.82 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aino Health AB EV-to-EBIT Related Terms
Aino Health AB EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Aino Health AB's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Aino Health AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aino Health AB EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aino Health AB's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Aino Health AB's EV-to-EBIT falls into.
Aino Health AB's current Enterprise Value is €3.91 Mil.
Aino Health AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.82 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aino Health AB (FRA:50V) has a EV-to-EBIT of -4.78 as of Aug. 19, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Aino Health AB and its competitors. According to the industry distribution chart, Aino Health AB ranks #999999 out of 473 companies in the Healthcare Providers & Services industry.
Is Aino Health AB's EV-to-EBIT too high?
Aino Health AB's current EV-to-EBIT is -4.78. Based on the distribution chart, Aino Health AB ranks #999999 out of 473 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Aino Health AB has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Aino Health AB's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Aino Health AB ranks #999999 out of 473 companies for EV-to-EBIT. This places Aino Health AB in the lower half of its industry. The industry median EV-to-EBIT is 15.81. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.81, based on 473 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Aino Health AB and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aino Health AB's current EV-to-EBIT is -4.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aino Health AB stock overvalued right now?
Aino Health AB (FRA:50V) has a current EV-to-EBIT of -4.78. The current EV-to-EBIT is -4.78. Aino Health AB's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Aino Health AB (FRA:50V), the current EV-to-EBIT is -4.78 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aino Health AB provides corporate health management solutions. The company has developed a complete system of IT-based services with a focus on improving corporate health and reducing sickness absence levels in private and public organizations. Its solution consists of HealthManager, HealthDesk, and Consulting services. Company SaaS platform combines advance data analytics, research-based insights, and AI to empower leaders to unlock the full potential of their teams and to foster a healthier, more sustainable work environment.
33GF Score
Get the complete analysis for FRA:50V
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:50V has been successfully added to your 
